Tucuvi has monitored more than 17,000 patients and has worked on more than eight different pathologies. The startup's business model is that of a B2B2C. Customers...
Unlike traditional venture capital, Clave Capital's model focuses on innovations linked to research environments and injects capital from the outset, even before the company is incorporated....
Angelini Industries had already focused on innovation, particularly in Indusriy 4.0, by investing in the Forward Factory accelerator launched by Cdp Venture Capital sgr. Forward Factory...
The Iqvia report also focuses on the place of origin of the research. This confirms the decline that is being experienced in Europe in the field...
Ability Pharma is working on a drug capable of inducing cancer cell death through autophagy. ABTL0812 has demonstrated clinical efficacy in a Phase II clinical trial...
Some of the big companies in the biotech sector have already outlined their plans for the new phase. For now, the largest U.S. biotech companies have...
The prices of the devices marketed by 24Genetics range from approximately 99 euros to 400 euros. The company offers different DNA tests: ancestry, nutrigenetic, pharmaceutical, health,...
CaixaResearch promotes cutting-edge research in health and biomedicine. The "la Caixa" Foundation's call for health research supports 33 projects of excellence from universities and research centers...
GE Healthcare is divided into four areas. The first is imaging (with X-ray equipment, for example), ultrasound, patient care solutions, and pharmaceuticals. The company's annual turnover...
Bayer posted a profit of €2.99 billion in the first half of 2022, compared with a loss of €246 million in the first half of last...